about
Dual drive coexistence of EML4-ALK and TPM3-ROS1 fusion in advanced lung adenocarcinoma.The rationale for druggability of CCDC6-tyrosine kinase fusions in lung cancer.CEP72-ROS1: A novel ROS1 oncogenic fusion variant in lung adenocarcinoma identified by next-generation sequencing.Targeting rearrangements in non-small cell lung cancer with crizotinib and other kinase inhibitors
P2860
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Recent Advances in Targeting ROS1 in Lung Cancer.
@en
type
label
Recent Advances in Targeting ROS1 in Lung Cancer.
@en
prefLabel
Recent Advances in Targeting ROS1 in Lung Cancer.
@en
P2860
P1476
Recent Advances in Targeting ROS1 in Lung Cancer.
@en
P2093
Alice T Shaw
Jessica J Lin
P2860
P356
10.1016/J.JTHO.2017.08.002
P577
2017-08-14T00:00:00Z